ABSI

Absci Corporation - Common Stock (ABSI)

About Absci Corporation - Common Stock (ABSI)

Absci Corp. engages in drug discovery with generative design to create biologics for patients. Its platform combines AI models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. The firm has its own pipeline of AI designed therapeutics including ABS-201 and ABS-202. Absci Corp was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Details

Daily high

$10.26

Daily low

$9.51

Price at open

$9.83

52 Week High

$12.54

52 Week Low

$2.24

Market cap

1.6B

Dividend yield

Volume

4.2M

Avg. volume

3.8M

P/E ratio

-11.73

Absci Corporation - Common Stock News